Valuation GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Delayed NSE India S.E. Other stock markets 11:08:13 08/07/2026 am IST			5-day change	1st Jan Change
2,424.30 ^INR	+0.74%		-1.07%	-2.00%

29/05	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
13/05	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,81,714	2,24,319	3,29,173	4,87,432	3,86,822	4,07,066	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	5.23%	-
Enterprise Value (EV)	2,56,351	2,07,663	3,29,173	4,87,432	3,86,822	4,07,066	4,07,066
Change	-	-18.99%	58.51%	48.08%	-20.64%	5.23%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	35.3x	31.1x
PBR	10.6x	12.9x	18.5x	25x	17.1x	15.3x	13x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.2x	2.3x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	9.71x	8.76x
EV / Revenue	0x	0x	0x	0x	0x	9.71x	8.76x
EV / EBITDA	0x	0x	0x	0x	0x	27.7x	24.4x
EV / EBIT	0x	0x	0x	0x	0x	29.6x	25.9x
EV / FCF	0x	0x	0x	0x	0x	35.1x	31.7x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.85%	3.16%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.23%	1.23%
EPS ²	100	36.05	34.83	54.76	61.15	67.98	77.28
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.4%	38.2%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,515	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,402.90	2,402.90
Nbr of stocks (in thousands)	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.12x	13.12x	26.72x	0.55%	1,10200Cr
JOHNSON & JOHNSON	28.52x	6.55x	17.81x	2%	64TCr
ABBVIE INC.	31.52x	7.52x	15.4x	2.69%	45TCr
ROCHE HOLDING AG	18.05x	4.49x	11.1x	2.95%	34TCr
NOVARTIS AG	21.91x	5.62x	13.6x	2.8%	29TCr
NOVO NORDISK A/S	14.45x	5.37x	11.03x	3.47%	22TCr
AMGEN INC.	24.08x	6.37x	11.22x	2.74%	20TCr
GILEAD SCIENCES, INC.	-48.34x	5.87x	32.62x	2.38%	17TCr
PFIZER INC.	11.78x	3.02x	7.46x	7.27%	14TCr
Average	15.34x	6.44x	16.33x	2.98%	39.39TCr
Weighted average by Cap.	24.29x	8.19x	18.81x	2.15%